Organizers postpone the EBCC-12 conference in view of the spread of coronavirus

In view of the spread of coronavirus (COVID-19), and the stipulation from the Spanish Healthcare Ministry that Spanish healthcare workers should not attend national or international conferences, the organizers of the 12th European Breast Cancer Conference (EBCC-12) have taken the decision to postpone the conference, which was due to start on Wednesday 18 March in Barcelona, Spain.

It will now take place from 30 September to 2 October 2020 at the same venue in Barcelona.

The EBCC-12 organizing committee have told participants and the wider breast cancer community that they feel a responsibility towards the 2,500 healthcare workers expected to attend EBCC-12 and their primary concern is for the health and welfare of all participants and staff, as well as the wider community.

They also believe that it is their collective responsibility to do what they can to minimise the risk of COVID-19 spreading further and to reduce the numbers of people travelling between countries at the present time.

This is the only truly multidisciplinary conference in Europe that involves all the major players in breast cancer, facilitating essential interaction and communication between scientists, clinicians and patient representatives. The organizers hope you will be able to attend in September and look forward to seeing all their many friends and colleagues then.

The organizing committee is continuing to monitor the situation and will provide further updates when necessary.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study unveils key mechanism behind prostate cancer's uncontrolled growth